cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.13385996
title: Supplementary Material for: Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern

description: <b><i>Background and Objectives:</i></b> Hidradenitis suppurativa (HS) and plaque psoriasis (Pso) are supposed to have a coprevalence. However, data showing a more detailed description of patients with both diseases are rare. In this study, we characterized patients with both skin diseases in terms of onset, disease course, severity, concomitant diseases and therapeutical management. <b><i>Patients and Methods:</i></b> Data from 28 patients with a confirmed codiagnosis of HS and Pso from 2 university hospitals presented between 2015 and 2019 were evaluated retrospectively. For further characterization, patients were divided into different cohorts depending on whether HS or Pso was diagnosed as the first disease. <b><i>Results:</i></b> The average age of patients with a coprevalence of both diseases was 44.4 years with a female/male ratio of 1:1.15. Fifteen patients were diagnosed first with HS at an average age of 22.8 years, 13 patients first showed symptoms of Pso at a mean age of 21.7 years. The average time to the onset of the corresponding second disease was 14.3 years. Patients with HS as first disease showed a significantly severer form of HS compared to patients with a first diagnosis of Pso (mean highest International Hidradenitis Suppurativa Severity Score System: 23.5 vs. 8.2; <i>p</i> = 0.02). Severity of psoriatic disease in patients with HS at first diagnosis was numerically lower but not significant compared to the cohort with Pso at first diagnosis (mean highest Psoriasis Area and Severity Index: 7.8 vs. 13.2; <i>p</i> = 0.299). The most frequent comorbidity in all patients was obesity (64.3%; mean body mass index: 32.2) followed by psychiatric complaints (25%) and psoriatic arthritis (21.4%). Adalimumab was the most commonly used drug that had a positive effect on both diseases, HS and Pso. <b><i>Conclusions:</i></b> In patients with a coprevalence of HS and Pso, the disease which occurs first appears to take a severer course, with an increased risk of development of obesity and psychiatric comorbidity in both cohorts.
DOI: 10.6084/m9.figshare.13385996.v1
title: Supplementary Material for: Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern

description: <b><i>Background and Objectives:</i></b> Hidradenitis suppurativa (HS) and plaque psoriasis (Pso) are supposed to have a coprevalence. However, data showing a more detailed description of patients with both diseases are rare. In this study, we characterized patients with both skin diseases in terms of onset, disease course, severity, concomitant diseases and therapeutical management. <b><i>Patients and Methods:</i></b> Data from 28 patients with a confirmed codiagnosis of HS and Pso from 2 university hospitals presented between 2015 and 2019 were evaluated retrospectively. For further characterization, patients were divided into different cohorts depending on whether HS or Pso was diagnosed as the first disease. <b><i>Results:</i></b> The average age of patients with a coprevalence of both diseases was 44.4 years with a female/male ratio of 1:1.15. Fifteen patients were diagnosed first with HS at an average age of 22.8 years, 13 patients first showed symptoms of Pso at a mean age of 21.7 years. The average time to the onset of the corresponding second disease was 14.3 years. Patients with HS as first disease showed a significantly severer form of HS compared to patients with a first diagnosis of Pso (mean highest International Hidradenitis Suppurativa Severity Score System: 23.5 vs. 8.2; <i>p</i> = 0.02). Severity of psoriatic disease in patients with HS at first diagnosis was numerically lower but not significant compared to the cohort with Pso at first diagnosis (mean highest Psoriasis Area and Severity Index: 7.8 vs. 13.2; <i>p</i> = 0.299). The most frequent comorbidity in all patients was obesity (64.3%; mean body mass index: 32.2) followed by psychiatric complaints (25%) and psoriatic arthritis (21.4%). Adalimumab was the most commonly used drug that had a positive effect on both diseases, HS and Pso. <b><i>Conclusions:</i></b> In patients with a coprevalence of HS and Pso, the disease which occurs first appears to take a severer course, with an increased risk of development of obesity and psychiatric comorbidity in both cohorts.
DOI: 10.34857/0062773
title: Fall Armyworm Evidence Note 2017

description: The purpose of the Evidence Note is to review current evidence of the potential impact of FAW in Africa, with the aim of: \r\n\u2022 assessing the likely social/economic impact on affected farmers and value chains \r\n\u2022 quantifying the likely economic effect on agricultural sectors in affected countries/regions if left unmanaged \r\n\u2022 recommending and prioritising control options which are economically appropriate and practical in the local context, with the aim of mitigating the prospective impact of FAW \r\n\u2022 identifying non-beneficial interventions \r\n\u2022 recommending next steps for FAW management \r\n\u2022 collating evidence of current FAW biology and ecology, and its future distribution
DOI: 10.21227/0snh-st12
title: Impact of Cognitive Biases on Progressive Visualization

description: This data is in support of the paper "Impact of Cognitive Biases on Progressive Visualization", currently under review.
DOI: 10.6084/m9.figshare.13264769.v3
title: agnostosDB_4eab867d-20201104

description: The dataset agnostosDB_4eab867d-20201104 constitutes an update of the agnostosDB+NCLDVs (a42ac58a-20200715) GC dataset, containing additional 10,207,435 eukaryotic plankton predicted gene sequences from 713 "SMAGs" (combination of 683 MAGs and 30 SAGs) (Delmont et al. 2020).<br>The agnostosDB+NCLDVs+Eukaryotic contains 6,572,081 refined GC with a total of 341,655,294 predicted genes.<br>A description of the dataset files is available in the README.txt file.<br><br>
DOI: 10.6084/m9.figshare.13385960
title: train4.zip

description: Fold 4 train set
DOI: 10.6084/m9.figshare.13385960.v1
title: train4.zip

description: Fold 4 train set
DOI: 10.34740/kaggle/dsv/1751719
title: LUFlow Network Intrusion Detection Data Set
DOI: 10.6084/m9.figshare.13251743.v2
title: agnostosDB_a42ac58a-20200715

description: The agnostosDB+NCLDVs (a42ac58a-20200715) is an update of the agnostosDB (dbf02445-20200519) GC dataset, containing the giant virus sequences from 3,243 nucleocytoplasmic large DNA viruses (NCLDVs) metagenome-assembled genomes (MAGs).<br>The agnostosDB+NCLDVs contains 5,383,876 refined GC with a total of 336,135,923 predicted genes.<br>A description of the dataset files is available in the README.txt file.<br>
DOI: 10.6084/m9.figshare.13264769
title: agnostosDB_4eab867d-20201104

description: The dataset agnostosDB_4eab867d-20201104 constitutes an update of the agnostosDB+NCLDVs (a42ac58a-20200715) GC dataset, containing additional 10,207,435 eukaryotic plankton predicted gene sequences from 713 "SMAGs" (combination of 683 MAGs and 30 SAGs) (Delmont et al. 2020).<br>The agnostosDB+NCLDVs+Eukaryotic contains 6,572,081 refined GC with a total of 341,655,294 predicted genes.<br>A description of the dataset files is available in the README.txt file.<br><br>
DOI: 10.6084/m9.figshare.13264769.v5
title: agnostosDB_4eab867d-20201104

description: The dataset agnostosDB_4eab867d-20201104 constitutes an update of the agnostosDB+NCLDVs (a42ac58a-20200715) GC dataset, containing additional 10,207,435 eukaryotic plankton predicted gene sequences from 713 "SMAGs" (combination of 683 MAGs and 30 SAGs) (Delmont et al. 2020).<br>The agnostosDB+NCLDVs+Eukaryotic contains 6,572,081 refined GC with a total of 341,655,294 predicted genes.<br>A description of the dataset files is available in the README.txt file.<br><br>
DOI: 10.6084/m9.figshare.13264769.v4
title: agnostosDB_4eab867d-20201104

description: The dataset agnostosDB_4eab867d-20201104 constitutes an update of the agnostosDB+NCLDVs (a42ac58a-20200715) GC dataset, containing additional 10,207,435 eukaryotic plankton predicted gene sequences from 713 "SMAGs" (combination of 683 MAGs and 30 SAGs) (Delmont et al. 2020).<br>The agnostosDB+NCLDVs+Eukaryotic contains 6,572,081 refined GC with a total of 341,655,294 predicted genes.<br>A description of the dataset files is available in the README.txt file.<br><br>
DOI: 10.6084/m9.figshare.13386071
title: Untitled Item

description: test
DOI: 10.6084/m9.figshare.13386071.v1
title: Untitled Item

description: test
DOI: 10.5281/zenodo.4327169
title: Inventaire provisoire des inscriptions khmères

description: Dominique Soutif et Julia Estève, <em>Inventaire provisoire des inscriptions khmères</em>
DOI: 10.15468/qvntwf
title: Advertisement call of two threatened red-bellied-toads Melanophryniscus cambaraensis and M. macrogranulosus (Anura: Bufonidae), from the Atlantic Rainforest, southern Brazil

description: This dataset contains the digitized treatments in Plazi based on the original journal article Caorsi, Valentina, Bordignon, Debora Wolff, Márquez, Rafael, Martins, Márcio Borges- (2020): Advertisement call of two threatened red-bellied-toads Melanophryniscus cambaraensis and M. macrogranulosus (Anura: Bufonidae), from the Atlantic Rainforest, southern Brazil. Zootaxa 4894 (2): 206-220, DOI: https://doi.org/10.11646/zootaxa.4894.2.2
DOI: 10.6084/m9.figshare.13386035
title: Supplementary Material for: Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy

description: <b><i>Introduction:</i></b> During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. <b><i>Methods:</i></b> Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with χ<sup>2</sup> or Fisher exact tests for categorical variables, and the Wilcoxon rank test for continuous variables. <b><i>Results:</i></b> In March-April 2020 the BC patient volume increased by 28% compared to the same period in 2019 (scheduled patients: 175 vs. 137) and amid travel restrictions it was kept high (treated patients: 136 vs. 133), mainly due to an influx from across Lombardy. RT schemes basically did not change, being already centered on hypofractionation. The increase of median time (67 vs. 74.5 days in 2019 and 2020, respectively) to the commencement of RT for low-risk patients was clinically negligible yet statistically significant (<i>p</i> = 0.03), and in line with the pertinent recommendations. No significant difference was found in the time interval between treatments and RT for high-risk patients. Concomitant chemoradiotherapy was avoided throughout the pandemic peak. Twenty-one women (13.6%) delayed either computed tomography simulation or RT commencement mainly because of COVID-19-related concerns and mobility restrictions. <b><i>Conclusion:</i></b> The workload for BC was high during the pandemic peak. Hubs allowed the continuation of oncologic treatments, while mitigating the strain on frontline COVID-19 hospitals.
DOI: 10.6084/m9.figshare.13386035.v1
title: Supplementary Material for: Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy

description: <b><i>Introduction:</i></b> During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. <b><i>Methods:</i></b> Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with χ<sup>2</sup> or Fisher exact tests for categorical variables, and the Wilcoxon rank test for continuous variables. <b><i>Results:</i></b> In March-April 2020 the BC patient volume increased by 28% compared to the same period in 2019 (scheduled patients: 175 vs. 137) and amid travel restrictions it was kept high (treated patients: 136 vs. 133), mainly due to an influx from across Lombardy. RT schemes basically did not change, being already centered on hypofractionation. The increase of median time (67 vs. 74.5 days in 2019 and 2020, respectively) to the commencement of RT for low-risk patients was clinically negligible yet statistically significant (<i>p</i> = 0.03), and in line with the pertinent recommendations. No significant difference was found in the time interval between treatments and RT for high-risk patients. Concomitant chemoradiotherapy was avoided throughout the pandemic peak. Twenty-one women (13.6%) delayed either computed tomography simulation or RT commencement mainly because of COVID-19-related concerns and mobility restrictions. <b><i>Conclusion:</i></b> The workload for BC was high during the pandemic peak. Hubs allowed the continuation of oncologic treatments, while mitigating the strain on frontline COVID-19 hospitals.
DOI: 10.5281/zenodo.4327160
title: Inventaire provisoire des inscriptions khmères : avant-propos

description: Dominique Soutif et Julia Estève, <em>Inventaire provisoire des inscriptions khmères : avant-propos</em>
DOI: 10.5281/zenodo.4327159
title: Inventaire provisoire des inscriptions khmères : avant-propos

description: Dominique Soutif et Julia Estève, <em>Inventaire provisoire des inscriptions khmères : avant-propos</em>
DOI: 10.6084/m9.figshare.13386005
title: 280399001009.xlsx

description: test
DOI: 10.6084/m9.figshare.13386005.v1
title: 280399001009.xlsx

description: test
DOI: 10.15468/h4eunx
title: Description of a second deep-water species in the alpheid shrimp genus Bannereus Bruce, 1988 (Malacostraca: Caridea)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Anker, Arthur, Pachelle, Paulo P. G. (2020): Description of a second deep-water species in the alpheid shrimp genus Bannereus Bruce, 1988 (Malacostraca: Caridea). Zootaxa 4894 (1): 133-142, DOI: https://doi.org/10.11646/zootaxa.4894.1.8
DOI: 10.5258/soton/d1662
title: Dataset for: Widely-tunable synchronisation-free picosecond laser source for multimodal CARS, SHG and two-photon microscopy

description: This dataset supports the publication: Xu, D, Price, J, Xu, L & Richardson, 'Widely-tunable synchronisation-free picosecond laser source for multimodal CARS, SHG and two-photon microscopy', Biomedical Optics Express. https://doi.org/10.1364/BOE.411620
DOI: 10.6084/m9.figshare.13386044
title: train5.zip

description: Fold 5 train set
DOI: 10.6084/m9.figshare.13386044.v1
title: train5.zip

description: Fold 5 train set
DOI: 10.5281/zenodo.4247265
title: Data to accompany S. Boissier et al., "Coherent characterisation of a single molecule in a photonic black box," (2020)

description: Data to accompany S. Boissier et al., "Coherent characterisation of a single molecule in a photonic black box," (2020). Data is in csv format and the "README.txt" file provides further details.
DOI: 10.5281/zenodo.4247264
title: Data to accompany S. Boissier et al., "Coherent characterisation of a single molecule in a photonic black box," (2020)

description: Data to accompany S. Boissier et al., "Coherent characterisation of a single molecule in a photonic black box," (2020). Data is in csv format and the "README.txt" file provides further details.
DOI: 10.5281/zenodo.4327220
title: Supplementary data for: "Global Venus-solar wind coupling and oxygen ion escape"

description: Supplementary data for paper "Global Venus-Solar wind coupling and oxygen ion escape", submitted to Geophysical Research Letters. See README file for description of the data in each file.
DOI: 10.5281/zenodo.4073191
title: Supplementary data for: "Global Venus-solar wind coupling and oxygen ion escape"

description: Supplementary data for paper "Global Venus-Solar wind coupling and oxygen ion escape", submitted to Geophysical Research Letters. See README file for description of the data in each file.
DOI: 10.34740/kaggle/dsv/1401928
title: US counties COVID 19 dataset
DOI: 10.5281/zenodo.4327257
title: Dataset used for the submitted manuscript "The hump-shaped effect of plant functional diversity on the biological control of a multi-species pest community"

description: Dataset
DOI: 10.5281/zenodo.4327256
title: Dataset used for the submitted manuscript "The hump-shaped effect of plant functional diversity on the biological control of a multi-species pest community"

description: Dataset
DOI: 10.5517/ccdc.csd.cc1p5dpy
title: CCDC 1554330: Experimental Crystal Structure Determination

description: Related Article: Denis Prodius, Matthew Klocke, Volodymyr Smetana, Tarek Alammar, Marilu Perez Garcia, Theresa L. Windus, Ikenna C. Nlebedim, Anja-Verena Mudring|2020|Chem.Commun.|56|11386|doi:10.1039/D0CC02270E
DOI: 10.5517/ccdc.csd.cc1p5dqz
title: CCDC 1554331: Experimental Crystal Structure Determination

description: Related Article: Denis Prodius, Matthew Klocke, Volodymyr Smetana, Tarek Alammar, Marilu Perez Garcia, Theresa L. Windus, Ikenna C. Nlebedim, Anja-Verena Mudring|2020|Chem.Commun.|56|11386|doi:10.1039/D0CC02270E
DOI: 10.5281/zenodo.4327012
title: LC MS/MS spectra

description: compilation of open source LC MS/MS databases necessary for MS2ID, an R annotation package
DOI: 10.5281/zenodo.4327011
title: LC MS/MS spectra

description: compilation of open source LC MS/MS databases necessary for MS2ID, an R annotation package
DOI: 10.15468/6ecyb6
title: New records of Indo-Pacific sponges from the Andaman and Nicobar Islands India

description: This dataset contains the digitized treatments in Plazi based on the original journal article Pereira, Preeti, Raghunathan, Chelladurai (2020): New records of Indo-Pacific sponges from the Andaman and Nicobar Islands India. Zootaxa 4894 (4): 81-97, DOI: https://doi.org/10.11646/zootaxa.4894.1.4
DOI: 10.6084/m9.figshare.13386329
title: Supplementary Material for: Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile

description: <b><i>Background:</i></b> Hemochromatosis gene (<i>HFE</i>)-associated hereditary hemochromatosis (HH) is characterized by downregulation of hepcidin synthesis, leading to increased intestinal iron absorption. <b><i>Objectives:</i></b> The objectives were to characterize and elucidate a possible association between gene expression profile, hepcidin levels, disease severity, and markers of inflammation in <i>HFE</i>-associated HH patients. <b><i>Methods:</i></b> Thirty-nine <i>HFE</i>-associated HH patients were recruited and assigned to 2 groups according to genetic profile: C282Y homozygotes in 1 group and patients with H63D, as homozygote or in combination with C282Y, in the other group. Eleven healthy first-time blood donors were recruited as controls. Gene expression was characterized from peripheral blood cells, and inflammatory cytokines and hepcidin-25 isoform were quantified in serum. Biochemical disease characteristics were recorded. <b><i>Results:</i></b> Elevated levels of interleukin 8 were observed in a significant higher proportion of patients than controls. In addition, compared to controls, gene expression of ζ-globin was significantly increased among C282Y homozygote patients, while gene expression of matrix metalloproteinase 8, and other neutrophil-secreted proteins, was significantly upregulated in patients with H63D. <b><i>Conclusion:</i></b> Different disease signatures may characterize HH patients according to their <i>HFE</i> genetic profile. Studies on larger populations, including analyses at protein level, are necessary to confirm these findings.
DOI: 10.6084/m9.figshare.13386329.v1
title: Supplementary Material for: Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile

description: <b><i>Background:</i></b> Hemochromatosis gene (<i>HFE</i>)-associated hereditary hemochromatosis (HH) is characterized by downregulation of hepcidin synthesis, leading to increased intestinal iron absorption. <b><i>Objectives:</i></b> The objectives were to characterize and elucidate a possible association between gene expression profile, hepcidin levels, disease severity, and markers of inflammation in <i>HFE</i>-associated HH patients. <b><i>Methods:</i></b> Thirty-nine <i>HFE</i>-associated HH patients were recruited and assigned to 2 groups according to genetic profile: C282Y homozygotes in 1 group and patients with H63D, as homozygote or in combination with C282Y, in the other group. Eleven healthy first-time blood donors were recruited as controls. Gene expression was characterized from peripheral blood cells, and inflammatory cytokines and hepcidin-25 isoform were quantified in serum. Biochemical disease characteristics were recorded. <b><i>Results:</i></b> Elevated levels of interleukin 8 were observed in a significant higher proportion of patients than controls. In addition, compared to controls, gene expression of ζ-globin was significantly increased among C282Y homozygote patients, while gene expression of matrix metalloproteinase 8, and other neutrophil-secreted proteins, was significantly upregulated in patients with H63D. <b><i>Conclusion:</i></b> Different disease signatures may characterize HH patients according to their <i>HFE</i> genetic profile. Studies on larger populations, including analyses at protein level, are necessary to confirm these findings.
DOI: 10.6084/m9.figshare.13386368
title: Supplementary Material for: The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series

description: <b><i>Background:</i></b> Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder (SMPLPD) is a provisional entity within the 2016 World Health Organization classification of primary cutaneous lymphomas. The condition is currently classified as a lymphoproliferative disorder to emphasize its benign course and discourage aggressive, systemic treatment modalities. <b><i>Objective:</i></b> To provide a relevant synthesis for the dermatological practitioner on the prevalence, presentation, and treatment of SMPLPD. <b><i>Methods:</i></b> We conducted an updated systematic literature review and a retrospective chart review of diagnosed cases of SMPLPD from 2 Canadian academic cutaneous lymphoma centers. <b><i>Results:</i></b> A total of 23 studies with 136 cases were extracted from the systematic review and 24 patients from our retrospective chart review. SMPLPD proved relatively common accounting for 12.5% of all cutaneous T-cell lymphomas encountered in our cutaneous lymphoma clinics, second in frequency only to mycosis fungoides. The typical clinical presentation was that of an older individual (median age 59 years) with an asymptomatic solitary lesion on their upper extremity. The most common clinical differentials were cutaneous lymphoid hyperplasia, basal cell carcinoma, and lymphoma unspecified. T follicular helper markers were reliably detected. The main treatment modalities were surgical excision, local radiation therapy, and topical or intralesional steroids. Cure was achieved in the vast majority of cases. <b><i>Conclusions:</i></b> SMPLPD is an underdiagnosed T-cell lymphoma with an overtly benign clinical course. The condition has an excellent prognosis and responds well to skin-directed therapies. Practitioners should be aware of this condition to avoid aggressive systemic treatments.